This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
This also includes additional requirements for pharmacies that engage in sterile and complex nonsterile compounding. California pharmacists are still able to provide the oral therapeutics without requiring you to visit your primary care physician through January 1, 2026.
Eliquis is still protected by patent rights in the UK, with exclusive availability rights until 2026 (IPO, 2021). . Apixaban stops the production of enzymes (chemicals) required for the production of fibrin , a compound (protein) that plays a role in the clotting of the blood. Apixaban vs warfarin: differences in licensed use.
By the end of 2026, the company will be able to analyze two million genomes. Marketing teams can easily collaborate with other departments and clients, sharing documents and files to create compelling campaigns. It is no surprise that the global market is growing at a compound annual rate of 20%.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
2026 
59 
Let's personalize your content